Radial scars and subsequent breast cancer risk: results from the Nurses' Health Studies

被引:31
作者
Aroner, Sarah A. [1 ]
Collins, Laura C. [2 ,3 ]
Connolly, James L. [2 ,3 ]
Colditz, Graham A. [4 ]
Schnitt, Stuart J. [2 ,3 ]
Rosner, Bernard A. [3 ,5 ,6 ]
Hankinson, Susan E. [3 ,5 ,7 ]
Tamimi, Rulla M. [1 ,3 ,5 ]
机构
[1] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02215 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
[4] Washington Univ, Sch Med, Dept Surg, St Louis, MO 63110 USA
[5] Brigham & Womens Hosp, Channing Div Network Med, Boston, MA 02115 USA
[6] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA
[7] Univ Massachusetts, Sch Publ Hlth & Hlth Sci, Div Biostat & Epidemiol, Amherst, MA 01003 USA
基金
美国国家卫生研究院;
关键词
Benign breast disease; Breast cancer; Breast pathology; Nested case-control; Radial scars; ATYPICAL HYPERPLASIA; MALIGNANT BREAST; NUCLEAR-ORGANIZATION; TUBULAR CARCINOMA; TISSUE STRUCTURE; GENE-EXPRESSION; DISEASE; LESIONS; BIOPSIES; WOMEN;
D O I
10.1007/s10549-013-2535-9
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Radial scars (RS) are benign proliferative lesions associated with an increased risk of subsequent breast cancer. However, it remains unclear whether RS are an independent risk factor for breast cancer or whether their association with breast cancer is due to their common occurrence with other proliferative lesions known to increase breast cancer risk. We performed an updated analysis of the association between RS and subsequent breast cancer risk in a nested case-control study among 460 cases and 1,792 controls with benign breast disease (BBD) in the Nurses' Health Studies. Logistic regression was used to estimate associations between RS in BBD biopsy specimens and breast cancer risk, adjusted for matching factors and breast cancer risk factors, including histologic category of concurrent BBD. In multivariable models prior to adjustment for histologic category of BBD, RS were associated with a twofold increased risk of breast cancer (odds ratio (OR) = 2.0; 95 % confidence interval (95 % CI) 1.4, 2.8). This association was attenuated but still significant after adjustment for BBD histologic category (OR = 1.6; 95 % CI 1.1, 2.3). In models adjusted for BBD histologic category and other covariates, risk appeared greater among women with multiple RS (1 RS, OR = 1.5; 95 % CI 0.9, 2.3; a parts per thousand yen2 RS, OR = 2.7; 95 % CI 1.5, 5.0; p-heterogeneity = 0.12). There were also suggestions of a greater risk associated with RS among women age a parts per thousand yen50 years at biopsy (p-heterogeneity = 0.07) and for estrogen receptor-negative/progesterone receptor-negative tumors compared with other hormone receptor subtypes (p-heterogeneity = 0.19). RS appear to be an independent histologic risk factor for breast cancer. Larger studies are needed to further evaluate whether risk is increased when multiple RS are present and whether associations vary by age at biopsy or by hormone receptor status of the breast tumor.
引用
收藏
页码:277 / 285
页数:9
相关论文
共 50 条
  • [1] Radial scars and subsequent breast cancer risk: results from the Nurses’ Health Studies
    Sarah A. Aroner
    Laura C. Collins
    James L. Connolly
    Graham A. Colditz
    Stuart J. Schnitt
    Bernard A. Rosner
    Susan E. Hankinson
    Rulla M. Tamimi
    Breast Cancer Research and Treatment, 2013, 139 : 277 - 285
  • [2] Lobule Type and Subsequent Breast Cancer Risk: Results From the Nurses' Health Studies
    Baer, Heather J.
    Collins, Laura C.
    Connolly, James L.
    Colditz, Graham A.
    Schnitt, Stuart J.
    Tamimi, Rulla M.
    CANCER, 2009, 115 (07) : 1404 - 1411
  • [3] Radial Scars and Subsequent Breast Cancer Risk: A Meta-Analysis
    Lv, Mengmeng
    Zhu, Xingya
    Zhong, Shanliang
    Chen, Weixian
    Hu, Qing
    Ma, Tengfei
    Zhang, Jun
    Zhang, Xiaohui
    Tang, Jinhai
    Zhao, Jianhua
    PLOS ONE, 2014, 9 (07):
  • [4] Breast cancer risk by extent and type of atypical hyperplasia: An update from the Nurses' Health Studies
    Collins, Laura C.
    Aroner, Sarah A.
    Connolly, James L.
    Colditz, Graham A.
    Schnitt, Stuart J.
    Tamimi, Rulla M.
    CANCER, 2016, 122 (04) : 515 - 520
  • [5] EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses' Health Studies
    Beca, Francisco
    Kensler, Kevin
    Glass, Benjamin
    Schnitt, Stuart J.
    Tamimi, Rulla M.
    Beck, Andrew H.
    BREAST CANCER RESEARCH, 2017, 19
  • [6] Reproductive risk factors in relation to molecular subtypes of breast cancer: Results from the nurses' health studies
    Sisti, Julia S.
    Collins, Laura C.
    Beck, Andrew H.
    Tamimi, Rulla M.
    Rosner, Bernard A.
    Eliassen, A. Heather
    INTERNATIONAL JOURNAL OF CANCER, 2016, 138 (10) : 2346 - 2356
  • [7] EZH2 protein expression in normal breast epithelium and risk of breast cancer: results from the Nurses’ Health Studies
    Francisco Beca
    Kevin Kensler
    Benjamin Glass
    Stuart J. Schnitt
    Rulla M. Tamimi
    Andrew H. Beck
    Breast Cancer Research, 19
  • [8] Recreational physical activity and breast cancer risk by menopausal status and tumor hormone receptor status: results from the Nurses' Health Studies
    Fortner, Renee T.
    Brantley, Kristen D.
    Tworoger, Shelley S.
    Tamimi, Rulla M.
    Rosner, Bernard
    Holmes, Michelle D.
    Willett, Walter C.
    Eliassen, A. Heather
    BREAST CANCER RESEARCH AND TREATMENT, 2024, 206 (01) : 77 - 90
  • [9] Risk factors for ductal and lobular breast cancer: results from the nurses' health study
    Joanne Kotsopoulos
    Wendy Y Chen
    Margaret A Gates
    Shelley S Tworoger
    Susan E Hankinson
    Bernard A Rosner
    Breast Cancer Research, 12
  • [10] Parity, breastfeeding, and breast cancer risk by hormone receptor status and molecular phenotype: results from the Nurses' Health Studies
    Fortner, Renee T.
    Sisti, Julia
    Chai, Boyang
    Collins, Laura C.
    Rosner, Bernard
    Hankinson, Susan E.
    Tamimi, Rulla M.
    Eliassen, A. Heather
    BREAST CANCER RESEARCH, 2019, 21 (1):